{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:11:37Z","timestamp":1765041097068,"version":"3.40.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>\n            The viral spike coat protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) engages the human ACE (angiotensin-converting enzyme) 2 cell surface receptor to infect the host cells. Thus, concerns arose regarding theoretically higher risk for coronavirus disease-19 (COVID-19) in patients taking ACE inhibitors\/angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs]). We systematically assessed case-population and cohort studies from MEDLINE (Ovid), Cochrane Database of Systematic Reviews PubMed, Embase, medRXIV, the World Health Organization database of COVID-19 publications, and\n            <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n            through June 1, 2020, with planned ongoing surveillance. We rated the certainty of evidence according to Cochrane methods and the Grading of Recommendations Assessment, Development and Evaluation approach. After pooling the adjusted odds ratios from the included studies, no significant increase was noted in the risk of SARS-CoV-2 infection by the use of ACE inhibitors (adjusted odds ratio, 0.95 [95% CI, 0.86\u20131.05]) or ARBs (adjusted odds ratio, 1.05 [95% CI, 0.97\u20131.14]). However, the random-effects meta-regression revealed that age may modify the SARS-CoV-2 infection risk in subjects with the use of ARBs (coefficient, \u22120.006 [95% CI, \u22120.016 to 0.004]), that is, the use of ARBs, as opposed to ACE inhibitors, specifically augmented the risk of SARS-CoV-2 infection in younger subjects (&lt;60 years old). The use of ACE inhibitors might not increase the susceptibility of SARS-CoV-2 infection, severity of disease, and mortality in case-population and cohort studies. Additionally, we discovered for the first time that the use of ARBs, as opposed to ACE inhibitors, specifically augmented the risk of SARS-CoV-2 infection in younger subjects, without obvious effects on COVID-19 outcomes.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.15989","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T10:00:21Z","timestamp":1598954421000},"page":"1563-1571","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection"],"prefix":"10.1161","volume":"76","author":[{"given":"Chieh-Kai","family":"Chan","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin Chu County (C.-K.C.)"},{"name":"Department of Internal Medicine (C.-K.C., Y.-S.H., J.-T.W., V.-C.W., T.-S.C.), National Taiwan University Hospital, Taipei"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine (C.-K.C., Y.-S.H.), National Taiwan University Hospital, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (C.-K.C., Y.-S.H., J.-T.W., V.-C.W., T.-S.C.), National Taiwan University Hospital, Taipei"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine (C.-K.C., Y.-S.H.), National Taiwan University Hospital, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Wei","family":"Liao","sequence":"additional","affiliation":[{"name":"Chinru Clinic, Taipei, Taiwan (H.-W.L.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Jung","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, National Taiwan University Children\u2019s Hospital, Taipei (I.-J.T.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Yin","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan (C.-Y.S., H.-C.P.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Chih","family":"Pan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Taiwan (C.-Y.S., H.-C.P.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S.","family":"Chueh","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine, OH (J.S.C.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (C.-K.C., Y.-S.H., J.-T.W., V.-C.W., T.-S.C.), National Taiwan University Hospital, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":true,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (C.-K.C., Y.-S.H., J.-T.W., V.-C.W., T.-S.C.), National Taiwan University Hospital, Taipei"},{"name":"NSARF (National Taiwan University Hospital Study Group of ARF), TAIPAI, (Taiwan Primary Aldosteronism Investigators), and CAKS (Taiwan Consortium for Acute Kidney Injury and Renal Diseases), Taipei (V.-C.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Shinn","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (C.-K.C., Y.-S.H., J.-T.W., V.-C.W., T.-S.C.), National Taiwan University Hospital, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the National Taiwan University Hospital Study Group of ARF, the Taiwan Primary Aldosteronism Investigators and the Taiwan Consortium for Acute Kidney Injury and Renal Diseases","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.02.034"},{"key":"e_1_3_4_3_2","unstructured":"World Health OrganizationWorld health organization (WHO) coronavirus disease (COVID-19) dashboard. https:\/\/covid19.Who.Int\/. Accessed May 5 2020"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.031"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31030-8"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1855"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa069"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f09f79"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.03.017"},{"key":"e_1_3_4_18_2","article-title":"Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea.","author":"Huh K","year":"2020","unstructured":"Huh, K, Ji, W, Kang, M, Hong, J, Bae, GH, Lee, R, Na, Y, Choi, H, Gong, SY, Jung, J. Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea. medRxiv. 2020:2020.2005.2004.20089904","journal-title":"medRxiv"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.09.20059964"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2007.041855"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040634"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2016.05.012"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002450"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu086"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.31.20118802"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882000117X"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/2042-6410-1-6"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14105"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4326"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30153-3"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104927"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h870"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1643-8"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f4edd7"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.15989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:04:09Z","timestamp":1715594649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.15989"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.15989"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.15989","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"type":"print","value":"0194-911X"},{"type":"electronic","value":"1524-4563"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"2020-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}